Characterization of human interleukin 2 derived from Escherichia coli. - Wikidata - wikimedia - TriplyDB

Characterization of human interleukin 2 derived from Escherichia coli.

Characterization of human interleukin 2 derived from Escherichia coli.

http://www.wikidata.org/entity/Q41953720

about

Enhancing the specificity of the enterokinase cleavage reaction to promote efficient cleavage of a fusion tag In vivo activation of lymphocytes in melanoma patients receiving escalating doses of recombinant interleukin 2.A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part II: Immunological aspects.The clinical effects of prolonged treatment of patients with advanced cancer with low-dose subcutaneous interleukin-2 [corrected]Strategies for achieving high-level expression of genes in Escherichia coli.Protease-catalyzed incorporation of 18O into peptide fragments and its application for protein sequencing by electrospray and matrix-assisted laser desorption/ionization mass spectrometry.Folding and Purification of Insoluble (Inclusion Body) Proteins from Escherichia coli.The purification of eukaryotic polypeptides synthesized in Escherichia coli.Regulation by glutathione of interleukin-4 activity on cytotoxic T cells.Purification and renaturation of recombinant human interleukin-2.Characterization of human and mouse granulocyte-macrophage-colony-stimulating factors derived from Escherichia coli Preparation and characterization of bovine growth hormones produced in recombinant Escherichia coli.C-terminal peptide identification by fast atom bombardment mass spectrometry Purification and refolding of Escherichia coli-expressed recombinant human interleukin-2.Characterization of recombinant glycosylated human interleukin 2 produced by a recombinant plasmid transformed CHO cell line.Purification and characterization of a high-molecular-weight form of recombinant human interleukin-2.Folding and purification of insoluble (inclusion body) proteins from Escherichia coli.The proteomics of N-terminal methionine cleavage.Production of human insulin in an E. coli system with Met-Lys-human proinsulin as the expressed precursor.Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes

P2860

Q30368803-B89ED84F-F246-4A65-9B03-DF264CA1ECDF Q33449077-4CE23919-6F98-4A51-B498-FE20F946638C Q35976681-E7DBAEA9-68C3-43B2-BCAC-151E8BB503AD Q35982992-2844CB50-F237-4624-A43F-E398FC05152B Q36671977-EE8AC9F0-7937-4204-9B12-6C992844DC0C Q36816844-73FD4E84-D4C9-4C51-8097-DB55E34155EB Q38264756-94F2A2EC-BC38-4F89-967C-B0757EB267B8 Q39760523-5F7D80CF-A24F-4F96-928F-236380FA6641 Q41636586-8E93B695-049F-4EB5-87C6-BAF9DD33DAF7 Q41781410-A891F6A3-0858-4BE2-B268-C86F0356FEB8 Q41822044-DE807DEB-A942-4125-ABB3-9589D5D80CDE Q42855973-D1C3A8BF-3F73-46D3-A25A-3C67539C5180 Q42857768-10DABAD6-BAEF-476A-8FF6-D8378C700DC1 Q43126371-42E9F800-8105-4158-B029-028F1970DF6B Q45074425-F2A5DD91-F3E6-4334-93A0-FB2B3790C021 Q47369153-F8B6D486-6E0F-4230-BAC2-04811EBB2B11 Q54423617-E6869E33-285A-42F3-85E8-69896B010D24 Q54455989-81D9812C-0F19-4B97-83B2-0E1AC6ECAA71 Q54603314-464508CA-E462-4B4F-9B95-3BC4A6AD0F45 Q59076874-0C4F3294-DA03-4F15-ABB4-56B5B401C011

P2860

Characterization of human interleukin 2 derived from Escherichia coli.

http://www.wikidata.org/entity/Q41953720

description

1985 nî lūn-bûn

@nan

1985年の論文

@ja

1985年論文

@yue

1985年論文

@zh-hant

1985年論文

@zh-hk

1985年論文

@zh-mo

1985年論文

@zh-tw

1985年论文

@wuu

1985年论文

@zh

1985年论文

@zh-cn

name

Characterization of human interleukin 2 derived from Escherichia coli.

@en

type

label

Characterization of human interleukin 2 derived from Escherichia coli.

@en

prefLabel

Characterization of human interleukin 2 derived from Escherichia coli.

@en

P1433

Q41953720-3C6F50B0-E2D1-4504-AC78-464D9894BA3D

P1476

Q41953720-E52AFC03-CB1A-4023-88A4-745B81FE5177

P2093

Q41953720-075C0ED4-A4FD-4072-8E7B-2C0C9AE4EC55

Q41953720-0ECEECE1-1821-4605-B619-A2AA11B44641

Q41953720-22E46347-19A9-4F7F-9FFF-8B80029F2A79

Q41953720-544F1C26-2FE0-4B9B-8ED9-2400104D2E5C

Q41953720-B0C5E954-836A-4FC5-9361-3CEF667B2F30

Q41953720-E1BB16E6-B49F-447B-B943-CD9241D9229F

P2860

Q41953720-0091712E-7428-4739-BE84-14B940AB856B

Q41953720-0C3F58E8-3897-458D-BE38-FB8398D36E96

Q41953720-168F9B24-5BC5-483C-BD2B-CFEBE16E07EA

Q41953720-1F63CC37-F76F-4CD7-9DCA-398799B0FEA2

Q41953720-2693112A-B3E1-4AA8-B144-484343CD547D

Q41953720-2D0F3E3F-B022-49F0-8489-A654E43E7E20

Q41953720-4C1E4CCE-F27D-4166-B012-9386D0FDF86B

Q41953720-4E9A1E1D-BA6C-4577-8C4D-4721CD92163E

Q41953720-4EF4FB40-A978-4B2A-843A-20DFB160C990

Q41953720-50015F6D-71FA-4156-AC9F-75EB8F9A2AED

P304

Q41953720-B722AF22-DF4F-425E-A7F8-546405B95024

P31

Q41953720-FB17E4C5-387B-4D36-A701-FEF772343AD2

P356

Q41953720-524FEF38-482B-45A0-B6A1-9490748770DB

P407

Q41953720-DA5F27E6-43CC-41F8-8A58-E7501488DADB

P433

Q41953720-54160F32-F0B9-443B-BC58-583DBBB05266

P478

Q41953720-0D4843F8-A716-4C66-9AF0-9D90E4749475

P577

Q41953720-B45FAF28-B075-4EC9-B318-12EF587F70FF

P5875

Q41953720-E683A966-F4E8-4B47-B7DA-DD6939DF2545

P698

Q41953720-68AF9872-78C5-422D-8983-1E846F64259C

P932

Q41953720-24DB0642-7A4E-442E-A9DB-C7D301823586

P356

P1433

Biochemical Journal

P1476

Characterization of human interleukin 2 derived from Escherichia coli.

@en

P2093

Allet B

http://www.w3.org/2001/XMLSchema#string

Hirschi M

http://www.w3.org/2001/XMLSchema#string

Liang CM

http://www.w3.org/2001/XMLSchema#string

Liang SM

http://www.w3.org/2001/XMLSchema#string

Rose K

http://www.w3.org/2001/XMLSchema#string

Thatcher DR

http://www.w3.org/2001/XMLSchema#string

P2860

Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

Prediction of protein conformation

Silver staining of proteins in polyacrylamide gels

On the release of the formyl group from nascent protein.

Selective in vitro growth of T lymphocytes from normal human bone marrows.

Purification to homogeneity and partial characterization of interleukin 2 from a human T-cell leukemia.

Human T-cell growth factor: partial amino acid sequence, cDNA cloning, and organization and expression in normal and leukemic cells

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

Dendritic cells induce T lymphocytes to release B cell-stimulating factors by an interleukin 2-dependent mechanism

P304

429-439

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1042/BJ2290429

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

229

http://www.w3.org/2001/XMLSchema#string

P577

1985-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

19263046

http://www.w3.org/2001/XMLSchema#string

P698

3899106

http://www.w3.org/2001/XMLSchema#string

P932

1145075

http://www.w3.org/2001/XMLSchema#string